IOL Chemicals and Pharmaceuticals Limited, a pioneer in the production of pharmaceuticals and specialty chemicals, has selected Vikas Vij as its new Chief Executive Officer. This appointment, which becomes effective on April 3, 2023, is set to elevate the company’s growth in both domestic and international markets. With over 30 years of experience in the pharma industry, including senior positions at Cipla, Ranbaxy, GVK Biosciences, Alembic Pharmaceuticals, Sun Pharma, and Apollo Hospitals, Vij brings a wealth of knowledge and a deep understanding of the pharma value chain to the role.
Joint Managing Director of IOL Chemicals and Pharmaceuticals, Vikas Gupta, said, “We’re excited to have Vikas Vij join us as CEO of IOL Chemicals and Pharmaceuticals. He’s a seasoned leader with a proven track record of driving sales and scaling businesses in the pharmaceutical and specialty chemicals arenas. With his extensive experience, we’re confident that he will steer IOL to new heights, both in India and in other markets.”
Vij, who succeeds Dr. Sanjay Chaturvedi, added, “I’m looking forward to working with the talented team at IOL to drive its next phase of growth. It’s a privilege to lead a company that is making such a positive impact on people’s lives and on the growth of the Indian Pharmaceutical Industry.”
IOL Chemicals and Pharmaceuticals is listed on the National Stock Exchange of India and the BSE and is a leading player in the specialty chemicals space. The company’s product portfolio includes APIs like Ibuprofen and specialty chemicals such as Ethyl Acetate, and it has a strong presence across major therapeutic categories. With a cutting-edge facility and a focus on sustainability, IOL Chemicals and Pharmaceuticals boasts an approved Effluent Treatment Plant with a Zero Liquid Discharge system and a 17 MW captive Co-Generation plant, demonstrating its commitment to responsible operations.
